Cariprazine exerts antimanic properties and interferes with dopamine D 2 receptor β ‐arrestin interactions-Reference-Cited by-同舟云学术

Cariprazine exerts antimanic properties and interferes with dopamine D 2 receptor β ‐arrestin interactions

Published:2014-12-02 Issue:1 Volume:3 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Gao Yonglin¹,Peterson Sean¹,Masri Bernard¹,Hougland M. Tyler²,Adham Nika³,Gyertyán Istvan⁴,Kiss Béla⁴,Caron Marc G.¹,El‐Mallakh Rif S.²

Affiliation:

1. Departments of Cell Biology, Medicine and NeurobiologyDuke University Medical Center DurhamNorth Carolina USA

2. Mood Disorders Research Program Department of Psychiatry and Behavioral Sciences University of Louisville School of Medicine MedCenter One, 501 East Broadway, Suite 340 Louisville Kentucky 40202

3. Forest Research InstituteDivision of Forest Laboratories, Inc.Jersey City New Jersey USA

4. Pharmacological and Drug Safety ResearchGedeon Richter Plc.Budapest Hungary

Funder

Forest Laboratories, Inc.

Gedeon Richter, Plc

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.73

Reference47 articles.

1. Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum

2. Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy

3. The Physiology, Signaling, and Pharmacology of Dopamine Receptors

4. The Akt–GSK-3 signaling cascade in the actions of dopamine

5. Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphine- and foot shock-responsive neuronal ensembles in the VTA possess different connectivity and biased GPCR signaling pathway;Theranostics;2024

2. Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data;European Neuropsychopharmacology;2023-07

3. Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism;Diabetes;2023-06-26

4. Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D _2L receptor;Fundamental & Clinical Pharmacology;2022-07-04

5. The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs;Frontiers in Pharmacology;2022-03-09